Inventor
Vinay Bhaskar
Inventor
San Francisco, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
C12NMicroorganisms or enzymes8%
PatentTitleYear
10,696,723Activatable interleukin 12 polypeptides202010,696,724Activatable interleukin-2 polypeptides202010,494,444Anti-CD38 antibodies201910,336,833Conjugated anti-CD38 antibodies20199,944,698Modulators20189,790,285'Anti-CD38 antibodies'20179,725,510'Modulators'20179,676,869'Conjugated anti-CD38 antibodies'20179,102,744'Conjugated anti-CD38 antibodies'20158,926,969'Anti-CD38 antibodies'20158,926,976'Modulators'20158,362,211'Anti-CD38 antibodies'20138,309,084'Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis'20128,257,708'Antibodies against cancer antigen TMEFF2 and uses thereof'20127,897,148'Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis'20117,879,987'Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis'20117,824,678'Antibodies against cancer antigen TMEFF2 and uses thereof'20107,807,163'Antibodies against GPR64 and uses thereof'20107,785,816'Antibodies against cancer antigen TMEFF2 and uses thereof'20107,776,585'Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis'20107,674,883'Antibodies against cancer antigen TMEFF2 and uses thereof'20107,662,384'Use of anti-α5β1 antibodies to inhibit cancer cell proliferation'20107,547,544'Antibodies against GPR64 and uses thereof'20097,288,248'Antibodies against cancer antigen TMEFF2 and uses thereof'20077,276,372'Antibodies against GPR64 and uses thereof'20077,276,589'Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007Patents assigned to PDL BIOPHARMA INC (3)· patent assignee history
2007–2020Based in San Francisco, CA, US· patent location history
2009–2011Patents assigned to FACET BIOTECH CORP (8)· patent assignee history
2011–2012Patents assigned to ABBOTT BIOTHERAPEUTICS CORP (3)· patent assignee history
2012–2015Patents assigned to BHASKAR VINAY (5)· patent assignee history
2015–2019Based in South San Francisco, CA, US· patent location history
2017–2019Patents assigned to TAKEDA PHARMACEUTICALS CO (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FACET BIOTECH CORP | 8 | 2009–2011 |
| BHASKAR VINAYself | 5 | 2012–2015 |
| TAKEDA PHARMACEUTICALS CO | 4 | 2017–2019 |
| ABBOTT BIOTHERAPEUTICS CORP | 3 | 2011–2012 |
| PDL BIOPHARMA INC | 3 | 2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 20 | 2007–2020 |
| South San Francisco, California, US | 6 | 2015–2019 |